Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions

키워드

참고문헌 (165)

1. de Jong K, "Disappointing interobserver agreement among radiologists for a classifying diagnosis of pancreatic cysts using magnetic resonance imaging", Pancreas, 41, pp.278~282 (2012)
2. Laffan TA, "Prevalence of unsuspected pancreatic cysts on MDCT", AJR Am J Roentgenol, 191, pp.802~807 (2008)
3. Girometti R, "Incidental pancreatic cysts on 3D turbo spin echo magnetic resonance cholangiopancreatography: prevalence and relation with clinical and imaging features", Abdom Imaging, 36, pp.196~205 (2011)
4. Zhang XM, "Pancreatic cysts: depiction on single-shot fast spin-echo MR images", Radiology, 223, pp.547~553 (2002)
5. Matsubara S, "Incidental pancreatic cysts found by magnetic resonance imaging and their relationship with pancreatic cancer", Pancreas, 41, pp.1241~1246 (2012)
6. Lee KS, "Prevalence of incidental pancreatic cysts in the adult population on MR imaging", Am J Gastroenterol, 105, pp.2079~2084 (2010)
7. Ip IK, "Focal cystic pancreatic lesions: assessing variation in radiologists’ management recommendations", Radiology, 259, pp.136~141 (2011)
8. Kimura W, "Analysis of small cystic lesions of the pancreas", Int J Pancreatol, 18, pp.197~206 (1995)
9. Gardner TB, "Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults", Am J Gastroenterol, 108, pp.1546~1550 (2013)
10. Valsangkar NP, "851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital", Surgery, 152(3), pp.S4~S12 (2012)
11. Crippa S, "Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients", Ann Surg, 247, pp.571~579 (2008)
12. Yamao K, "Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society", Pancreas, 40, pp.67~71 (2011)
13. Le Baleur Y, "Mucinous cystic neoplasms of the pancreas: definition of preoperative imaging criteria for high-risk lesions", Pancreatology, 11, pp.495~499 (2011)
14. Zamboni G, "Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors", Am J Surg Pathol, 23, pp.410~422 (1999)
15. Thompson LD, "Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases", Am J Surg Pathol, 23, pp.1~16 (1999)
16. Baker ML, "Invasive mucinous cystic neoplasms of the pancreas", Exp Mol Pathol, 93, pp.345~349 (2012)
17. Jimenez RE, "Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy", Ann Surg, 230, pp.501~509 (1999)
18. Iacobuzio-Donahue CA, "Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression", Am J Surg Pathol, 24, pp.1544~1548 (2000)
19. Wu J, "Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways", Proc Natl Acad Sci U S A, 108, pp.21188~21193 (2011)
20. Izumo A, "Mucinous cystic tumor of the pancreas: immunohistochemical assessment of “ovarian-type stroma”", Oncol Rep, 10, pp.515~525 (2003)
21. O’Toole D, "Macrocystic pancreatic cystadenoma: the role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions", Gastrointest Endosc, 59, pp.823~829 (2004)
22. Brugge WR, "Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study", Gastroenterology, 126, pp.1330~1336 (2004)
23. Tanaka M, "International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas", Pancreatology, 12, pp.183~197 (2012)
24. Galanis C, "Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment", J Gastrointest Surg, 11, pp.820~826 (2007)
25. Tseng JF, "Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment", Ann Surg, 242, pp.413~419 (2005)
26. Le Borgne J, "Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association", Ann Surg, 230, pp.152~161 (1999)
27. Bassi C, "Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa?", World J Surg, 27, pp.319~323 (2003)
28. Hochwald SN, "Magnetic resonance imaging with magnetic resonance cholangiopancreatography accurately predicts resectability of pancreatic carcinoma", J Gastrointest Surg, 3, pp.506~511 (1999)
29. Kimura W, "Multicenter study of serous cystic neoplasm of the Japan Pancreas Society", Pancreas, 41, pp.380~387 (2012)
30. King JC, "Pancreatic serous cystadenocarcinoma: a case report and review of the literature", J Gastrointest Surg, 13, pp.1864~1868 (2009)
31. Khashab MA, "Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms", Am J Gastroenterol, 106, pp.1521~1526 (2011)
32. Malleo G, "Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment", Gut, 61, pp.746~751 (2012)
33. Hwang HK, "Serous cyst adenoma of the pancreas: appraisal of active surgical strategy before it causes problems", Surg Endosc, 26, pp.1560~1565 (2012)
34. Menard A, "Serous cystadenomas of the pancreas: long-term follow-up measurement of growth rate", Can Assoc Radiol J, 62, pp.190~196 (2011)
35. Imaoka H, "Pancreatic endocrine neoplasm can mimic serous cystadenoma", Int J Gastrointest Cancer, 35, pp.217~220 (2005)
36. Sahara S, "Differentiation of pancreatic serous cystadenoma from endocrine tumor and intraductal papillary mucinous neoplasm based on washout pattern on multiphase CT", J Comput Assist Tomogr, 36, pp.231~236 (2012)
37. Hayashi K, "CT differentiation of solid serous cystadenoma vs endocrine tumor of the pancreas", Eur J Radiol, 81, pp.e203~e208 (2012)
38. Gerke H, "Hypervascular pancreatic tumor diagnosed as a serous cystadenoma by EUS-guided Trucut biopsy", Gastrointest Endosc, 64, pp.273~274 (2006)
39. Hammel PR, "Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel-Lindau", Gastroenterology, 119, pp.1087~1095 (2000)
40. Charlesworth M, "Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature", J Gastrointest Surg, 16, pp.1422~1428 (2012)
41. Panarelli NC, "Microcystic serous cystadenoma of the pancreas with subtotal cystic degeneration: another neoplastic mimic of pancreatic pseudocyst", Am J Surg Pathol, 36, pp.726~731 (2012)
42. Moore PS, "Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q", Am J Pathol, 158, pp.317~321 (2001)
43. Thirabanjasak D, "Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis?", Pancreatology, 9, pp.182~188 (2009)
44. Vassos N, "Solid-pseudopapillary neoplasm (SPN) of the pancreas: case series and literature review on an enigmatic entity", Int J Clin Exp Pathol, 6, pp.1051~1059 (2013)
45. Papavramidis T, "Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature", J Am Coll Surg, 200, pp.965~972 (2005)
46. Reddy S, "Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series", J Am Coll Surg, 208, pp.950~957 (2009)
47. Butte JM, "Solid pseudopapillary tumors of the pancreas: clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center", J Gastrointest Surg, 15, pp.350~357 (2011)
48. Serra S, "Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas", J Clin Pathol, 61, pp.1153~1159 (2008)
49. El-Bahrawy MA, "E-cadherin", catenin complex status in solid pseudopapillary tumor of the pancreas, 2008, pp.32, 1~7
50. Tanaka Y, "Frequent beta-catenin mutation and cytoplasmic", nuclear accumulation in pancreatic solid-pseudopapillary neoplasm, 2001, pp.61, 8401~8404
51. Chetty R, "Loss of expression of E-cadherin in solid pseudopapillary tumors of the pancreas", Pancreas, 38, pp.338~ (2009)
52. Abraham SC, "Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations", Am J Pathol, 160, pp.1361~1369 (2002)
53. Geers C, "Solid and pseudopapillary tumor of the pancreas: review and new insights into pathogenesis", Am J Surg Pathol, 30, pp.1243~1249 (2006)
54. Morales A, "Papillary-cystic neoplasm of the pancreas: a sex-steroid dependent tumor", Int J Pancreatol, 24, pp.219~225 (1998)
55. Fried P, "A role for radiotherapy in the treatment of solid and papillary neoplasms of the pancreas", Cancer, 56, pp.2783~2785 (1985)
56. Gaujoux S, "The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis", Surgery, 151, pp.518~525 (2012)
57. Boninsegna L, "Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior", Neuroendocrinology, 92, pp.246~251 (2010)
58. Bordeianou L, "Cystic pancreatic endocrine neoplasms: a distinct tumor type?", J Am Coll Surg, 206, pp.1154~1158 (2008)
59. Federle MP, "Cystic neoplasms of the pancreas", Gastroenterol Clin North Am, 36, pp.365~376 (2007)
60. Singhi AD, "Cystic pancreatic neuroendocrine tumors: a clinicopathologic study", Am J Surg Pathol, 36, pp.1666~1673 (2012)
61. Ho HC, "Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: a multicentre case series", Dig Liver Dis, 45, pp.750~753 (2013)
62. Ligneau B, "Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases", Am J Surg Pathol, 25, pp.752~760 (2001)
63. Kongkam P, "EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors", Endoscopy, 40, pp.602~605 (2008)
64. Goh BK, "Clinico-pathological features of cystic pancreatic endocrine neoplasms and a comparison with their solid counterparts", Eur J Surg Oncol, 32, pp.553~556 (2006)
65. Yoon WJ, "Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine-needle aspiration characteristics", Endoscopy, 45, pp.189~194 (2013)
66. Davtyan H, "Pancreatic cystic endocrine neoplasms", Pancreas, 5, pp.230~233 (1990)
67. Kamisawa T, "Okamoto A. A case of malignant cystic endocrine tumor of the pancreas", Am J Gastroenterol, 82, pp.86~89 (1987)
68. Fernández-del Castillo C, "Cystic tumors of the pancreas", Surg Clin North Am, 75, pp.1001~1016 (1995)
69. Lee LC, "Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management", Surgery, 152, pp.965~974 (2012)
70. Fernández-del Castillo C, "Intraductal papillary mucinous neoplasms of the pancreas", Gastroenterology, 139, pp.708~713 (2010)
71. Adsay NV, "Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients", Cancer, 94, pp.62~77 (2002)
72. Fukushima N, "Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases", Virchows Arch, 439, pp.6~13 (2001)
73. Klöppel G, "Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas", Hepatogastroenterology, 45, pp.1981~1985 (1998)
74. Cuillerier E, "Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas", Am J Gastroenterol, 95, pp.441~445 (2000)
75. Crippa S, "Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics", Clin Gastroenterol Hepatol, 8, pp.213~219 (2010)
76. Furukawa T, "Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas", Gut, 60, pp.509~516 (2011)
77. Farrell JJ, "Pancreatic cystic neoplasms: management and unanswered questions", Gastroenterology, 144, pp.1303~1315 (2013)
78. Sohn TA, "Intraductal papillary mucinous neoplasms of the pancreas: an updated experience", Ann Surg, 239, pp.788~797 (2004)
79. Maguchi H, "Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan", Pancreas, 40, pp.364~370 (2011)
80. Lévy P, "Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy", Clin Gastroenterol Hepatol, 4, pp.460~468 (2006)
81. Wasif N, "Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes", Cancer, 116, pp.3369~3377 (2010)
82. Adsay NV, "Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas", Am J Surg Pathol, 28, pp.839~848 (2004)
83. Poultsides GA, "Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas", Ann Surg, 251, pp.470~476 (2010)
84. Mino-Kenudson M, "Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes", Gut, 60, pp.1712~1720 (2011)
85. Lüttges J, "The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma", Am J Surg Pathol, 25, pp.942~948 (2001)
86. Furukawa T, "Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study", Virchows Arch, 447, pp.794~799 (2005)
87. Sadakari Y, "Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type", Surgery, 147, pp.812~817 (2010)
88. Strobel O, "Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia", Gastroenterology, 138, pp.1166~1177 (2010)
89. Canto MI, "Frequent detection of pancreatic lesions in asymptomatic high-risk individuals", Gastroenterology, 142, pp.796~804 (2012)
90. Hruban RH, "Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions", Am J Surg Pathol, 25, pp.579~586 (2001)
91. Basturk O, "Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis", Am J Surg Pathol, 34, pp.364~370 (2010)
92. Patel SA, "Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas", Am J Surg Pathol, 26, pp.1071~1077 (2002)
93. Tajiri T, "Histologic and immunohistochemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas", Pancreas, 29, pp.116~122 (2004)
94. Kanda M, "Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia", Clin Gastroenterol Hepatol, 11, pp.719~730 (2013)
95. Xiao HD, "Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms", J Pathol, 224, pp.508~516 (2011)
96. Wu J, "Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development", Sci Transl Med, 3, pp.92~66 (2011)
97. Dal Molin M, "Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas", Ann Surg Oncol, 20, pp.3802~3808 (2013)
98. Matthaei H, "Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas", Ann Surg, 255, pp.326~333 (2012)
99. Hong SM, "Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas", Clin Cancer Res, 18, pp.700~712 (2012)
100. Hong SM, "Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer", Clin Cancer Res, 18, pp.4303~4312 (2012)
101. Habbe N, "MicroRNA miR-155 is a biomarker of early pancreatic neoplasia", Cancer Biol Ther, 8, pp.340~346 (2009)
102. Farrell JJ, "Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer", Am J Gastroenterol, 108, pp.1352~1359 (2013)
103. Matthaei H, "miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts", Clin Cancer Res, 18, pp.4713~4724 (2012)
104. Rebours V, "Familial intraductal papillary mucinous neoplasms of the pancreas", Dig Liver Dis, 44, pp.442~446 (2012)
105. Ingkakul T, "Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions", Pancreas, 40, pp.779~780 (2011)
106. Hara H, "Cytologic study of noninvasive intraductal papillary-mucinous carcinoma of the pancreas", Acta Cytol, 46, pp.519~526 (2002)
107. Kurihara K, "Biliopancreatic fistula associated with intraductal papillary-mucinous pancreatic cancer: institutional experience and review of the literature", Hepatogastroenterology, 47, pp.1164~1167 (2000)
108. Yamaguchi K, "Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN", Pancreas, 40, pp.571~580 (2011)
109. Ideno N, "Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype", Ann Surg, 258, pp.141~151 (2013)
110. Correa-Gallego C, "Incidental pancreatic cysts: do we really know what we are watching?", Pancreatology, 10, pp.144~150 (2010)
111. Tanaka M, "International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas", Pancreatology, 6, pp.17~32 (2006)
112. Fritz S, "Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas", Surgery, 152(3), pp.S74~S80 (2012)
113. Wong J, "High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound", J Gastrointest Surg, 17, pp.78~84 (2013)
114. Tang RS, "Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm", Clin Gastroenterol Hepatol, 6, pp.815~819 (2008)
115. Rodriguez JR, "Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection", Gastroenterology, 133, pp.72~79 (2007)
116. Pelaez-Luna M, "Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients", Am J Gastroenterol, 102, pp.1759~1764 (2007)
117. Weinberg BM, "Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms", Gastroenterology, 138, pp.531~540 (2010)
118. Tanno S, "Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results", Gut, 57, pp.339~343 (2008)
119. Mori Y, "Management strategy for multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas.", Pancreas, 41, pp.1008~1012 (2012)
120. Berland LL, "Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee", J Am Coll Radiol, 7, pp.754~773 (2010)
121. Nehra D, "Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter?", Pancreatology, 12, pp.358~363 (2012)
122. Kang MJ, "Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms", Clin Gastroenterol Hepatol, 9, pp.87~93 (2011)
123. Miller JR, "Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm", HPB, 13, pp.759~766 (2011)
124. Khannoussi W, "The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas", Pancreatology, 12, pp.198~202 (2012)
125. Osiro S, "Is preoperative diagnosis possible? A clinical and radiological review of lymphoepithelial cysts of the pancreas", JOP, 14, pp.15~20 (2013)
126. Nasr J, "Lymphoepithelial cysts of the pancreas: an EUS case series", Gastrointest Endosc, 68, pp.170~173 (2008)
127. Coe A, "The yield of EUS-FNA in undiagnosed upper abdominal adenopathy is very high", J Clin Ultrasound, 41, pp.210~213 (2013)
128. Jathal A, "Diagnosis of pancreatic cystic lymphangioma with EUS-guided FNA: report of a case", Gastrointest Endosc, 61, pp.920~922 (2005)
129. Bhatia V, "Cystic pancreatic lymphangioma: the first report of a preoperative pathological diagnosis by endoscopic ultrasound-guided cyst aspiration", JOP, 12, pp.473~476 (2011)
130. Paik KY, "Solid tumors of the pancreas can put on a mask through cystic change", World J Surg Oncol, 9, pp.79~ (2011)
131. Sahani DV, "Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas", Clin Gastroenterol Hepatol, 7, pp.259~269 (2009)
132. Chaudhari VV, "Pancreatic cystic lesions: discrimination accuracy based on clinical data and high resolution CT features", J Comput Assist Tomogr, 31, pp.860~867 (2007)
133. Kim JH, "Diagnostic performance of MRI and EUS in the differentiation of benign from malignant pancreatic cyst and cyst communication with the main duct", Eur J Radiol, 81, pp.2927~2935 (2012)
134. Lee LS, "EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors", Clin Gastroenterol Hepatol, 3, pp.231~236 (2005)
135. Pitman MB, "High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than “positive” cytology", Cancer Cytopathol, 118, pp.434~440 (2010)
136. van der Waaij LA, "Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis", Gastrointest Endosc, 62, pp.383~389 (2005)
137. Othman MO, "Carcino embryonic antigen and long-term follow-up of mucinous pancreatic cysts including intraductal papillary mucinous neoplasm", Dig Liver Dis, 44, pp.844~848 (2012)
138. Al-Haddad M, "Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts", Gastrointest Endosc, 79, pp.79~87 (2014)
139. Siddiqui AA, "EUS-guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: a pilot study", Gastrointest Endosc, 77, pp.669~670 (2013)
140. Rockacy MJ, "Association between KRAS mutation, detected in pancreatic cyst fluid, and long-term outcomes of patients", Clin Gastroenterol Hepatol, 11, pp.425~429 (2013)
141. Mertz H, "K-ras mutations correlate with atypical cytology and elevated CEA levels in pancreatic cystic neoplasms", Dig Dis Sci, 56, pp.2197~2201 (2011)
142. Toll AD, "The added value of molecular testing in small pancreatic cysts", JOP, 11, pp.582~586 (2010)
143. Shen J, "Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis", Cancer, 117, pp.217~227 (2009)
144. Sreenarasimhaiah J, "A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts", JOP, 10, pp.163~168 (2009)
145. Sawhney MS, "Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid", Gastrointest Endosc, 69, pp.1106~1110 (2009)
146. Khalid A, "Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study", Gastrointest Endosc, 69, pp.1095~1102 (2009)
147. Gan SI, "Ethanol lavage of pancreatic cystic lesions: initial pilot study", Gastrointest Endosc, 61, pp.746~752 (2005)
148. Oh HC, "Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts", Gastroenterology, 140, pp.172~179 (2011)
149. Oh HC, "EUS-guided pancreatic cyst ablation: a critical review", Gastrointest Endosc, 77, pp.526~533 (2013)
150. Oh HC, "Ablate under EUS-guidance when properly indicated", Gastroenterology, 141, pp.e20~e21 (2011)
151. Oh HC, "New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection", Gastrointest Endosc, 67, pp.636~642 (2008)
152. Oh HC, "Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts", Gastroenterology, 140, pp.172~179 (2011)
153. DeWitt J, "EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study", Gastrointest Endosc, 70, pp.710~723 (2009)
154. Imaoka H, "Pancreatic endocrine neoplasm can mimic serous cystadenoma", Int J Gastrointest Cancer, 35, pp.217~220 (2005)
155. Gerke H, "Hypervascular pancreatic tumor diagnosed as a serous cystadenoma by EUS-guided Trucut biopsy", Gastrointest Endosc, 64, pp.273~274 (2006)
156. Salvia R, "Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop?", JOP, 6(1), pp.112~117 (2005)
157. Gaujoux S, "Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period", J Am Coll Surg, 212, pp.590~600 (2011)
158. Sahora K, "Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series", Ann Surg, 258, pp.466~475 (2013)
159. Lee LS, "Interdisciplinary management of cystic neoplasms of the pancreas", Gastroenterol Res Pract, 2012, pp.513163~ (2012)
160. Lennon AM, "Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study", Ann Surg Oncol, 21, pp.3668~3674 (2014)
161. Nair RM, "Interdisciplinary management of an intraductal papillary mucinous neoplasm of the pancreas", Cancer Control, 15, pp.322~333 (2008)
162. Jabbar KS, "Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer", J Natl Cancer Inst, 106 (2014)
163. Maker AV, "Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas", Ann Surg Oncol, 18, pp.199~206 (2011)
164. Carrara S, "Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies", Am J Gastroenterol, 106, pp.1359~1363 (2011)
165. Ryu JK, "Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma", Pancreatology, 11, pp.343~350 (2011)

관련 논문AI추천